TCL Archive In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area November 8, 1985
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer March 26, 2010